AORT

Artivion (AORT)

Artivion Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:AORT

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/08/28	05 : 47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:AORT	Artivion Inc
2024/08/27	06 : 08	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:AORT	Artivion Inc
2024/08/20	05 : 58	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:AORT	Artivion Inc
2024/08/17	05 : 44	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:AORT	Artivion Inc
2024/08/17	00 : 38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:AORT	Artivion Inc
2024/08/16	06 : 30	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:AORT	Artivion Inc
2024/08/15	23 : 37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:AORT	Artivion Inc
2024/08/14	03 : 33	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:AORT	Artivion Inc
2024/08/10	00 : 47	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NYSE:AORT	Artivion Inc
2024/08/09	05 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:AORT	Artivion Inc
2024/08/09	05 : 05	PR Newswire (US)	Artivion Reports Second Quarter 2024 Financial Results	NYSE:AORT	Artivion Inc
2024/08/06	05 : 10	PR Newswire (US)	Artivion to Participate in Upcoming Investor Conferences	NYSE:AORT	Artivion Inc
2024/07/26	05 : 10	PR Newswire (US)	Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2024 Financial Results	NYSE:AORT	Artivion Inc
2024/07/02	05 : 05	PR Newswire (US)	Artivion Amends Agreements with Endospan	NYSE:AORT	Artivion Inc
2024/06/03	21 : 44	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:AORT	Artivion Inc
2024/06/03	21 : 41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:AORT	Artivion Inc
2024/06/03	21 : 38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:AORT	Artivion Inc
2024/06/03	21 : 36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:AORT	Artivion Inc
2024/06/03	21 : 33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:AORT	Artivion Inc
2024/06/03	21 : 29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:AORT	Artivion Inc
2024/06/03	21 : 24	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:AORT	Artivion Inc
2024/06/03	21 : 22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:AORT	Artivion Inc
2024/05/31	05 : 12	Edgar (US Regulatory)	Form SD - Specialized disclosure report	NYSE:AORT	Artivion Inc
2024/05/18	05 : 14	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:AORT	Artivion Inc
2024/05/17	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:AORT	Artivion Inc
2024/05/14	07 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:AORT	Artivion Inc
2024/05/11	07 : 04	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:AORT	Artivion Inc
2024/05/11	06 : 12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:AORT	Artivion Inc
2024/05/10	06 : 53	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:AORT	Artivion Inc
2024/05/08	01 : 07	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NYSE:AORT	Artivion Inc